Influenza Season Update: Trends, Data, and Emerging Threats
Did you know the influenza vaccine can prevent heart attacks in people with heart disease just as effectively as quitting smoking or taking statins?
Course Information
- Audience: All public health professionals working in nonprofits, healthcare, educational institutions, government and private sector
- Format: Webinar
- Date/Time: Thursday, October 3, 2024 12:00 PM – 1:00 PM ET.
- Price: Free
- Length: 1 hour
- Credential(s) eligible for contact hours: Sponsored by New England Public Health Training Center (NEPHTC), a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1 total Category I continuing education contact hours. Maximum advanced-level continuing education contact hours are 1. Provider ID: Event ID: .If you are not seeking a CHES/MCHES contact hours, if you complete the post-test and evaluation, you will receive a Certificate of Completion. The Certificate will include the length of the course.
- Competencies: Policy Development and Program Planning Skills
- Learning Level: Awareness
- Companion Trainings: None
- Supplemental materials:None
- Pre-requisites: None
About this Webinar
Dr. Andrew Rennekamp from CSL Seqirus will present an overview of influenza-associated disease and prevention, focusing on annual CDC vaccination recommendations, current vaccination rates, and the latest influenza vaccine technologies. He will also provide an update on the ongoing H5 highly pathogenic avian influenza (HPAI) outbreak affecting birds, cows, and farm workers, along with the U.S. government’s response.
What you'll learn
After attending this webinar, participants will be able to:
- Illustrate the annual burden of influenza in the U.S., including non-respiratory complications
- Explain the challenges associated with flu prevention
- Classify the current types of flu vaccines used in the U.S. and evaluate their safety and effectiveness
- Summarize the ongoing H5 highly pathogenic avian influenza (HPAI) outbreak in the U.S. and discover your role in pandemic prevention and preparedness
Subject Matter Experts
Dr. Andrew Rennekamp
Dr. Andrew Rennekamp is a Senior Medical Science Liaison at CSL Seqirus and an influenza expert. He holds a Ph.D. in Virology from the University of Pennsylvania and completed his fellowship at Massachusetts General Hospital and Harvard Medical School. With nearly 20 years of research experience, Dr. Rennekamp transitioned to a Scientific Editor role at the journal Cell, leading immunology, vaccine, biotech, and COVID-19 publishing from 2017 to 2021. He joined CSL Seqirus in January 2022 and represents Medical Affairs for the company in U.S. Northeast.
Registration
Select the Enroll Me button below to register for this recording. If you have any trouble accessing the recording, contact support@nephtc.org.
Enroll Me
Acknowledgement: This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of award 2 UB6HP31685‐05‐00 “Public Health Training Centers.” The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS or the U.S. Government.